Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-12-20
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines, http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
pubmed:status
MEDLINE
pubmed:issn
0507-3758
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
492-500
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15605777-Anthracyclines, pubmed-meshheading:15605777-Antibiotics, Antineoplastic, pubmed-meshheading:15605777-Antibodies, Monoclonal, pubmed-meshheading:15605777-Antibodies, Monoclonal, Humanized, pubmed-meshheading:15605777-Antineoplastic Agents, Alkylating, pubmed-meshheading:15605777-Antineoplastic Agents, Phytogenic, pubmed-meshheading:15605777-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15605777-Breast Neoplasms, pubmed-meshheading:15605777-Carboplatin, pubmed-meshheading:15605777-Chemotherapy, Adjuvant, pubmed-meshheading:15605777-Clinical Trials, Phase III as Topic, pubmed-meshheading:15605777-Cyclophosphamide, pubmed-meshheading:15605777-Data Interpretation, Statistical, pubmed-meshheading:15605777-Disease Progression, pubmed-meshheading:15605777-Doxorubicin, pubmed-meshheading:15605777-Epirubicin, pubmed-meshheading:15605777-Female, pubmed-meshheading:15605777-Humans, pubmed-meshheading:15605777-Neoadjuvant Therapy, pubmed-meshheading:15605777-Neoplasm Metastasis, pubmed-meshheading:15605777-Paclitaxel, pubmed-meshheading:15605777-Randomized Controlled Trials as Topic, pubmed-meshheading:15605777-Risk Assessment, pubmed-meshheading:15605777-Risk Factors, pubmed-meshheading:15605777-Taxoids, pubmed-meshheading:15605777-Time Factors
pubmed:year
2004
pubmed:articleTitle
[Role of taxanes in treatment of breast cancer].
pubmed:publicationType
Comparative Study, Lectures